Perspective Therapeutics (CATX) Liabilities from Discontinued Operations (2022 - 2024)
Perspective Therapeutics (CATX) posted Liabilities from Discontinued Operations of 5070000.0 for Q1 2024, little changed sequentially from 5072000.0 in Q4 2023.
Perspective Therapeutics (CATX) Liabilities from Discontinued Operations (2022 - 2024) Analysis & Trends
Perspective Therapeutics has reported Liabilities from Discontinued Operations for 3 years, with the latest figure at 5070000.0 in Q1 2024.
- Quarterly Liabilities from Discontinued Operations changed N/A year-over-year to 5070000.0 in Q1 2024, while the trailing twelve-month figure through Mar 2024 was 5070000.0 (changed N/A YoY) and the FY2023 annual result came in at 5072000.0, up 1737.68% from the prior year.
- Liabilities from Discontinued Operations steadied at 5070000.0 in Q1 2024 per CATX's latest filing, from 5072000.0 in the prior quarter.
- Over five years, Liabilities from Discontinued Operations peaked at 5072000.0 in Q4 2023 and troughed at 276000.0 in Q4 2022.
- A 3-year average of 3472666.67 and a median of 5070000.0 in 2024 frame the typical range for Liabilities from Discontinued Operations.
- The widest YoY moves for Liabilities from Discontinued Operations: up 1737.68% in 2023, down 1737.68% in 2023.
- Over 3 years, Liabilities from Discontinued Operations stood at 276000.0 in 2022, then surged by 1737.68% to 5072000.0 in 2023, then fell by 0.04% to 5070000.0 in 2024.
- According to Business Quant data, Liabilities from Discontinued Operations over the past three periods registered 5070000.0, 5072000.0, and 276000.0 for Q1 2024, Q4 2023, and Q4 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn |
| 10 | Perspective Therapeutics | 384.88 Mn | 384.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 5.07 Mn |
| Mar 31, 2024 | 5.07 Mn |
| Dec 31, 2023 | 5.07 Mn |
| Dec 31, 2023 | 5.07 Mn |
| Dec 31, 2022 | 276,000.00 |
| Dec 31, 2022 | 276,000.00 |